|1.||Négrier, C: 6 articles (05/2015 - 07/2006)|
|2.||Berntorp, E: 6 articles (09/2013 - 11/2003)|
|3.||Livnat, T: 3 articles (08/2015 - 07/2008)|
|4.||Martinowitz, U: 3 articles (08/2015 - 07/2008)|
|5.||Gringeri, A: 3 articles (09/2013 - 01/2011)|
|6.||Yee, T T: 3 articles (05/2013 - 01/2010)|
|7.||Shima, M: 3 articles (03/2013 - 07/2004)|
|8.||Turecek, P L: 3 articles (01/2013 - 11/2003)|
|9.||Astermark, Jan: 3 articles (02/2008 - 11/2002)|
|10.||Gringeri, Alessandro: 3 articles (02/2008 - 06/2006)|
|1.||Hemophilia A (Haemophilia)
04/01/2007 - "Excellent hemostasis was obtained in all cases, adding to accumulating data indicating that FEIBA is safe and effective in hemophilia patients with inhibitors who require surgery."
01/01/2014 - "Given the high risk for morbidity and mortality in haemophilia patients with inhibitors to FVIII or FIX, we conducted this Phase 3 prospective study to evaluate whether prophylaxis with FEIBA NF is a safe and effective treatment option. "
11/01/2009 - "FEIBA provides an effective and safe first-line peri- and postoperative haemostatic therapy for patients with haemophilia A and inhibitors, allowing both major and minor operations to be successfully performed."
05/01/2015 - "FEIBA prophylaxis was effective for preventing joint bleeds and subsequent joint damage, delaying arthropathy and improving outcomes in children with haemophilia A and inhibitors to FVIII, who failed or were ineligible for ITI. "
09/01/2014 - "This study investigates whether 12-month of FEIBA prophylaxis improved HRQoL in haemophilia patients with inhibitors. "
05/01/2015 - "FEIBA was effective in managing 88.0% of bleeding episodes (95% confidence interval, 75.8-94.5%). "
05/01/2012 - "FEIBA was judged effective in 92% of treatment courses for acute bleeding, with a 95% confidence interval (CI) of 85-97%. "
05/01/2003 - "Studies have not been presented to show the safety and efficacy of FEIBA when given over a long period of time to prevent haemophilic arthropathy with bleeding into the joints of these patients. "
01/01/2014 - "This study demonstrates that FEIBA prophylaxis significantly reduces all types of bleeding compared with on-demand treatment, and the safety of prophylaxis is comparable to that of on-demand treatment."
01/01/2010 - "This study was performed to assess the effectiveness and safety of early prophylaxis with FEIBA in preventing bleeding and joint damage after failed ITI. "
|3.||Subdural Hematoma (Subdural Hemorrhage)
06/01/2015 - "We report a case of a patient receiving apixaban who developed a spontaneous subdural hematoma and declining mental status that improved after administration of a single dose of factor eight inhibitor bypassing activity. "
06/01/2015 - "Management of apixaban-associated subdural hematoma: a case report on the use of factor eight inhibitor bypassing activity."
04/01/2014 - "Favorable outcome after a subdural hematoma treated with feiba in a 77-year-old patient treated by rivaroxaban."
08/01/2015 - "Spiking thrombocytopenia blood with FEIBA led to reduction of CT. "
08/01/2015 - "The results of this study suggest that combined spiking of blood with fibrinogen and FEIBA may be enough to correct the clot formation disorder in severe thrombocytopenia, whereas in thrombocytopenia and blood dilution, additive inhibition of fibrinolysis may be needed."
08/01/2015 - "Dilution of thrombocytopenia blood was followed by reduction of α-Angle and MCF compared to nondiluted blood which partly reversed by either fibrinogen or FEIBA being higher using fibrinogen and FEIBA together. "
|1.||recombinant FVIIa (rFVIIa)
|3.||Prothrombin (Factor II)
|4.||Factor VIIa (Activated Factor VII)
|5.||Antifibrinolytic Agents (Antifibrinolytics)
|8.||recombinant factor VIII SQ
|9.||Factor VIII (Coagulation Factor VIII)
|10.||prothrombin complex concentrates (PPSB)
|2.||Chest Tubes (Chest Tube)
|3.||Minor Surgical Procedures (Minor Surgery)
|4.||Male Circumcision (Circumcision)